Clinical Trial

Assessing the Effectiveness and Safety of Pericapsular Nerve Group (PENG) Block in Hip Fracture Patients on Antithrombotic Therapy

Study acronym: PENG Block
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated September 3, 2024 (before its estimated January 17, 2025 completion). Its status may not reflect the trial's current state.
Summary
PENG block will be done on patients with hip fracture either receiving antithrombotic therapy or not under ultrasound guidance
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06582667
Lead Sponsor Alexandria University
Conditions Hip Fracture, Antithrombotic Therapy, PENG Block
Enrollment 100 participants
Start Date 2024-09-17
Primary Completion 2025-01-17 (estimated)
Study Completion 2025-04-17 (estimated)
Updated on ClinicalTrials.gov 2024-09-03